Tailoring national HIV programs to better meet people's needs

"The features of the global HIV epidemic vary by country, often by community and patient, and it's important to understand these distinctions so that we can design programs to meet people's needs and strengthen their access to treatment and prevention," Bill Gates, co-chair of the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog. He describes how the Department of Health in South Africa's Western Cape "is delivering health care to the thousands of people living with HIV in the townships and rural areas surrounding the city of Cape Town." Gates discusses the program in the Western Cape in detail, noting its flexibility in tailoring treatment to each patient, efficient use of "scarce health care resources," and focus on data collection. "[W]e still face a situation where only half of all people who could benefit from HIV treatment are actually receiving it," he writes, concluding, "And that means we have a moral obligation to be smarter about how we organize treatment programs so that people in treatment are able to live longer and so that fewer people die for lack of access to treatment" (4/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PrEPVacc HIV vaccine trial shows no reduction in infections